FDA — authorised 30 May 2003
- Application: NDA021528
- Marketing authorisation holder: ABBVIE
- Local brand name: ACULAR LS
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA authorised Ketorolac 0.5% Eye Drops on 30 May 2003
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 30 May 2003; FDA has authorised it.
ABBVIE holds the US marketing authorisation.